Octreotide acetate
USP/1477604 - United States Pharmacopeia (USP) Reference Standard
Synonym: Octreotide acetate salt
CAS Number: 79517-01-4
Empirical Formula (Hill Notation): C49H66N10O10S2 · xC2H4O2
Molecular Weight: 1019.24 (free base basis)
MDL Number: MFCD08277638
Linear Formula: C49H66N10O10S2 · xC2H4O2
Product Type: Chemical
| API family | octreotide |
| application(s) | USP Biologics pharmaceutical (small molecule) |
| form | powder |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C49H66N10O10S2.2C2H4O2 |
| InChI key | QWFYIFWTVZFPRY-AARKYNAGSA |
| manufacturer/tradename | USP |
| SMILES string | S1SCC(C(=O)NC(C(=O)NC(C(= |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | This USP reference standard is intended for use in specified quality tests and assays. Also used to prepare standard and system suitability solutions in the assay of octreotide acetate as described in the United States Pharmacopeia (USP) monograph. |
| General description: | Octreotide acetate is a synthetic cyclic octapeptide that mimics natural somatostatin, inhibiting the release of growth hormone, insulin, and glucagon. It is used therapeutically in acromegaly and neuroendocrine tumors. The USP reference standard enables identity, potency, and impurity testing in octreotide drug products. The USP biologics peptides category encompasses a diverse range of therapeutic peptides that are essential in managing various medical conditions. These peptides, typically consisting of amino acid sequences of 40 residues or less, are critical for the development of high-quality medicines. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of peptide therapeutics throughout their lifecycle. The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics. |
| Other Notes: | Sales restrictions may apply. |
| Other Notes: | This product is part of the USP Biologics program. |
| Other Notes: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia ![]() |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |

